Intelligent Bio Solutions Inc.
INBS
$2.40
$0.051.92%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 45.53% | 47.62% | 27.46% | 15.95% | -11.52% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 45.53% | 47.62% | 27.46% | 15.95% | -11.52% |
| Cost of Revenue | 35.59% | 13.68% | 12.94% | 679.59% | -39.95% |
| Gross Profit | 56.82% | 106.05% | 49.45% | -58.85% | 91.26% |
| SG&A Expenses | 1.82% | 29.18% | 36.47% | 1.78% | -0.46% |
| Depreciation & Amortization | -3.84% | -7.63% | 1.00% | 5.55% | -5.30% |
| Other Operating Expenses | 4.39% | 45.58% | -53.29% | -392.81% | -106.80% |
| Total Operating Expenses | 21.69% | 22.05% | 7.01% | 5.25% | -12.93% |
| Operating Income | -14.90% | -15.20% | -0.46% | -2.49% | 13.32% |
| Income Before Tax | -12.50% | -19.04% | -11.14% | -10.99% | 14.60% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -12.50% | -19.04% | -11.14% | -10.99% | 14.60% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -2.82% | 23.29% | 30.43% | 12.61% | -21.98% |
| Net Income | -12.55% | -19.03% | -11.07% | -10.99% | 14.58% |
| EBIT | -14.90% | -15.20% | -0.46% | -2.49% | 13.32% |
| EBITDA | -14.83% | -20.35% | 0.15% | -2.08% | 8.99% |
| EPS Basic | 59.26% | 43.22% | 50.47% | 51.78% | 69.22% |
| Normalized Basic EPS | 59.32% | 43.80% | 54.84% | 55.23% | 69.21% |
| EPS Diluted | 59.26% | 43.22% | 50.47% | 51.87% | 69.22% |
| Normalized Diluted EPS | 59.32% | 43.80% | 54.84% | 55.23% | 69.21% |
| Average Basic Shares Outstanding | 176.25% | 109.61% | 124.27% | 130.15% | 177.50% |
| Average Diluted Shares Outstanding | 176.25% | 109.61% | 124.27% | 130.15% | 177.50% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |